Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Patrick L. McCollam"'
Autor:
Arun Krishnamoorthy, Eric D. Peterson, J. David Knight, Kevin J. Anstrom, Mark B. Effron, Marjorie E. Zettler, Linda Davidson‐Ray, Brian A. Baker, Patrick L. McCollam, Daniel B. Mark, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 1 (2016)
BackgroundLongitudinal clinical investigations often rely on patient reports to screen for postdischarge adverse outcomes events, yet few studies have examined the accuracy of such patient reports. Methods and ResultsPatients with acute myocardial in
Externí odkaz:
https://doaj.org/article/6166945ddd524b4c9e537468d0ce47b8
Autor:
Erik Hille, Mark Belger, Patrick L. McCollam, Theodore Spiro, Russel Burge, KA Kelton, Tim Klein, Daniel R Murphy
Publikováno v:
Advances in Therapy
Introduction Baricitinib–remdesivir (BARI-REM) combination is superior to remdesivir (REM) in reducing recovery time and accelerating clinical improvement among hospitalized patients with coronavirus disease 2019 (COVID-19), specifically those rece
Autor:
Yajun Zhu, Brian R. Murphy, Beth L. Nordstrom, Patrick L. McCollam, Mark B. Effron, Cliff Molife, Robert L. Page, Kavita V. Nair, Stuart Keller, Jason C. Simeone, George W. Vetrovec
Publikováno v:
American Journal of Cardiovascular Drugs. 18:129-141
No direct comparisons of ticagrelor and prasugrel with 1-year clinical follow-up have been reported. Our objective was to compare 1-year clinical outcomes among patients with acute coronary syndrome (ACS) managed with percutaneous coronary interventi
Autor:
Y. Zhu, Robert L. Page, Jason C. Simeone, Beth L. Nordstrom, Mark B. Effron, Stuart Keller, Brian R. Murphy, Elizabeth Marrett, Patrick L. McCollam, Cliff Molife, George W. Vetrovec, Kavita V. Nair, Feride Frech-Tamas
Publikováno v:
American Journal of Cardiovascular Drugs. 15:337-350
Our objective was to compare 1-year real-world healthcare resource utilization (HRU), associated charges, and antiplatelet treatment patterns among patients with acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI) and
Autor:
Elizabeth Marrett, Feride Frech-Tamas, Cliff Molife, Jingsong Lu, Swapna Karkare, Patrick L. McCollam, Cynthia Larmore, George W. Vetrovec, Mark B. Effron, Mitch DeKoven, Yajun Zhu
Publikováno v:
Journal of Medical Economics. 18:898-908
Objective:To compare healthcare resource utilization (HCRU) and healthcare costs in patients with acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI) and treated with prasugrel or ticagrelor.Methods:Hospital charge mas
Autor:
Linda Davidson-Ray, Patrícia O. Guimarães, Tracy Y. Wang, Arun Krishnamoorthy, Daniel B. Mark, Patrick L. McCollam, Eric D. Peterson, Kevin J. Anstrom, Lisa A. Kaltenbach, Mark B. Effron
Publikováno v:
JAMA cardiology. 2(7)
Importance Pragmatic clinical trial designs have proposed the use of medical claims data to ascertain clinical events; however, the accuracy of billed diagnoses in identifying potential events is unclear. Objectives To compare the 1-year cumulative i
Autor:
Tracy Y. Wang, Patrick L. McCollam, Linda Davidson-Ray, Kevin J. Anstrom, Lisa A. Kaltenbach, Eric D. Peterson, Patrícia O. Guimarães, Daniel B. Mark, Arun Krishnamoorthy, Mark B. Effron
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 10
Background: Pragmatic clinical trial designs have proposed the use of claims data to ascertain clinical events. However, little is known about the accuracy of medical claims diagnosis in identifying events. Methods: Administrative claims were obtaine
Autor:
Thomas M. Maddox, Fengming Tang, Julie Birt, Patrick L. McCollam, Suzanne V. Arnold, Zhenxiang Zhao, John A. Spertus, Mikhail Kosiborod
Publikováno v:
Circulation. 129:1303-1309
Background— Intensive statins are superior to moderate statins in reducing morbidity and mortality after an acute myocardial infarction. Although studies have documented rates of statin prescription as a quality performance measure, variations in h
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Autor:
JP Bae, LeRoy LeNarz, Johnna Anderson, Baojin Zhu, Patrick L. McCollam, Haoda Fu, Zhenxiang Zhao, Marjie Zettler
Publikováno v:
Current Medical Research and Opinion. 27:633-641
Recent guidelines recommend use of aspirin and either clopidogrel or prasugrel for at least 12 months following use of drug-eluting or bare metal stents in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PC